Soleno Therapeutics, Inc. - SLNO
About Gravity Analytica
Recent News
- 06.10.2025 - Goldman Sachs 46th Healthcare Conference
- 06.10.2025 - Goldman Sachs 46th Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 06.04.2025 - Jefferies Global Healthcare Conference
- 05.22.2025 - Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
- 05.22.2025 - Soleno Therapeutics Announces Submission and EMA Validation of Marketing Authorization Application for Diazoxide Choline Prolonged-Release Tablets for the Treatment of Hyperphagia in Patients with Prader-Willi Syndrome
- 05.21.2025 - Soleno Therapeutics to Participate in Upcoming June Conferences
- 05.21.2025 - Soleno Therapeutics to Participate in Upcoming June Conferences
- 05.20.2025 - Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Wil
- 05.20.2025 - Soleno Therapeutics Announces Data Presentation Showing that Resumption of Treatment with VYKAT(TM) XR after a Randomized Withdrawal Period was Associated with Significant Improvements in Hyperphagia and Behavioral Symptoms in Participants with Prader-Willi Syndrome